Kyverna Therapeutics(US:KYTX) Prnewswire·2025-01-13 10:45Core Viewpoint - The Gross Law Firm has announced a class action lawsuit on behalf of shareholders of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) who purchased shares during the specified class period related to the company's February 2024 initial public offering [1][2]. Group 1: Allegations - The complaint alleges that during the class period, the defendants made materially false and misleading statements and failed to disclose critical information regarding the IPO strategy, terms, and disclosures in the Offering Documents [2]. - It is claimed that the underwriter defendants should have been aware of Kyverna's undisclosed problems and the inaccuracies in the Offering Documents due to ongoing communications with the company's management and legal representatives [2]. Group 2: Class Action Details - The deadline for shareholders to register for the class action is February 7, 2025, and they are encouraged to register to receive updates on the case [3]. - Shareholders who register will be enrolled in a portfolio monitoring software to keep them informed throughout the lifecycle of the case [3]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit and illegal business practices [4]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [4].